DeepMed Research

UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Phase 2

Recruiting

Conditions: Radiotherapy
Stage 4 NSCLC

Interventions: Radiation: Prophylactic Palliative Radiotherapy

First Posted Date: 2024-02-16

Last Posted Date: 2024-06-11

Lead Sponsor: University of Rochester

Target Recruit Count: 48

Registration Number: NCT06262321

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

Not Applicable

Not yet recruiting

Conditions: Egg Allergy
Peanut and Nut Allergy
Allergy and Immunology
Food Allergy in Infants
Food Allergy Peanut

Interventions: Behavioral: Consumption
Behavioral: Avoidance

First Posted Date: 2024-02-15

Last Posted Date: 2025-04-04

Lead Sponsor: University of Rochester

Target Recruit Count: 500

Registration Number: NCT06260956

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Lafiya HIV Self-testing Study Protocol

Not Applicable

Recruiting

Conditions: HIV Prevention and Care

Interventions: Behavioral: LAFIYA

First Posted Date: 2024-02-02

Last Posted Date: 2025-03-18

Lead Sponsor: University of Rochester

Target Recruit Count: 40

Registration Number: NCT06238323

Locations: 🇬🇭
University of Ghana, Accra, Ghana

Early-onset Dupilumab Effects in CRSwNP

Phase 4

Withdrawn

Conditions: Chronic Rhinosinusitis With Nasal Polyps

Interventions: Drug: Dupilumab

First Posted Date: 2024-01-03

Last Posted Date: 2024-05-09

Lead Sponsor: University of Rochester

Registration Number: NCT06188871

Locations: 🇺🇸
University of Rochester Department of Otolaryngology Head and Neck Surgery, Rochester, New York, United States

Effect of Visual Retraining After Stroke

Not Applicable

Conditions: Vision Loss Partial
Vision; Loss, Both Eyes
Hemianopia
Stroke, Ischemic
Cortical Blindness
Hemianopia Homonymous
Quadrantanopia
Stroke - Occipital Infarction

Interventions: Device: Training in the Blind Field

First Posted Date: 2023-11-07

Last Posted Date: 2024-11-13

Lead Sponsor: University of Rochester

Target Recruit Count: 100

Registration Number: NCT06121219

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Regulating Together in Tuberous Sclerosis Complex

Not Applicable

Recruiting

Conditions: TSC
Behavioral Symptoms

Interventions: Behavioral: Behavioral Intervention in a small group platform

First Posted Date: 2023-10-30

Last Posted Date: 2024-06-11

Lead Sponsor: University of Rochester

Target Recruit Count: 105

Registration Number: NCT06105736

Locations: 🇺🇸
University of North Carolina Chapel Hill-Carolina Institute for Developmental Disabilities, Carrboro, North Carolina, United States
🇺🇸
Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, United States

Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

Phase 4

Active, not recruiting

Conditions: Respiratory Syncytial Virus (RSV)

Interventions: Biological: RSV vaccine

First Posted Date: 2023-10-11

Last Posted Date: 2024-03-18

Lead Sponsor: University of Rochester

Target Recruit Count: 152

Registration Number: NCT06077149

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Reducing Frailty for Older Cancer Survivors Using Supplements II

Phase 2

Recruiting

Conditions: Inflammation
Frailty

Interventions: Drug: Epigallocatechin-3-Gallate (EGCG)
Drug: Microcrystalline cellulose (MCC)
Dietary Supplement: Ascorbic Acid (Vitamin C)

First Posted Date: 2023-10-05

Last Posted Date: 2025-01-29

Lead Sponsor: University of Rochester

Target Recruit Count: 118

Registration Number: NCT06068543

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®

Not Applicable

Recruiting

Conditions: Well-Being, Psychological

Interventions: Behavioral: Health Protection and Promotion
Behavioral: General Health Program

First Posted Date: 2023-09-28

Last Posted Date: 2024-12-19

Lead Sponsor: University of Rochester

Target Recruit Count: 133

Registration Number: NCT06058949

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses

Phase 2

Not yet recruiting

Conditions: Abscess

Interventions: Drug: Methylene Blue
Drug: Lipid Emulsion
Device: Insertion of optical fiber
Device: Laser Illumination (pre-defined dose)
Device: Optical Spectroscopy Measurement
Procedure: Standard of care abscess drainage
Device: Laser Illumination (patient-specific dose)

First Posted Date: 2023-09-25

Last Posted Date: 2025-05-02

Lead Sponsor: University of Rochester

Target Recruit Count: 90

Registration Number: NCT06052956

Locations: 🇺🇸
Highland Hospital, Rochester, New York, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy